A Note to Our Shareholders:
We know many of you are waiting for updates regarding our OTC Markets access. That process remains underway, and we look forward to communicating through our official disclosure channels as soon as access is restored.
In the meantime, our team remains focused on execution and building the business. Management continues to invest alongside our shareholders because we believe in our vision and the future we are creating together.
Thank you for your patience, trust, and continued support.
One Vision. One Purpose. Unlimited Possibilities.
$EMBR
To our shareholders and supporters,
Trust is earned—not given.
Our management team has been working diligently to position the company for its next chapter, and we look forward to sharing additional updates as they become appropriate for public release.
As previously reported, we have completed two strategic acquisitions—one in the premium spirits industry and one in the regenerative medicine sector. These milestones reflect our commitment to building a diversified company with a disciplined, long-term strategy.
We believe in the future of this company. That confidence is reflected in our actions, as members of management have invested alongside our shareholders because we believe our interests should always be aligned with yours.
As CEO, I am committed to earning your trust through execution, transparency, and accountability. We will continue to communicate openly, execute with discipline, and let our results speak for themselves.
Thank you for your continued confidence and support.
One Vision. One Purpose. Unlimited Possibilities.
— Mark A. Jones
President & CEO
$EMBR